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SUMMARY 1 
Infections due to multidrug-resistant bacteria represent a major global health challenge. 2 
To combat this problem, new antibiotics are urgently needed and some plant-3 
associated bacteria are a promising source. The rhizobacterium Serratia plymuthica 4 
A153 produces several bioactive secondary metabolites, including the anti-oomycete 5 
and antifungal haterumalide, oocydin A, and the broad spectrum polyamine antibiotic, 6 
zeamine. In this study, we show that A153 produces a second broad spectrum 7 
antibiotic, andrimid. Using genome sequencing, comparative genomics and 8 
mutagenesis, we defined new genes involved in andrimid (adm) biosynthesis. Both the 9 
expression of the adm gene cluster and regulation of andrimid synthesis were 10 
investigated. The biosynthetic cluster is operonic and its expression is modulated by 11 
various environmental cues, including temperature and carbon source. Analysis of the 12 
genome context of the adm operon revealed a gene encoding a predicted LysR-type 13 
regulator, AdmX, apparently unique to Serratia strains. Mutagenesis and gene 14 
expression assays demonstrated that AdmX is a transcriptional activator of the adm 15 
gene cluster. At the post-transcriptional level, the expression of the adm cluster is 16 
positively regulated by the RNA chaperone, Hfq, in an RpoS-independent manner. Our 17 
results highlight the complexity of andrimid biosynthesis - an antibiotic with potential 18 
clinical and agricultural utility. 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
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INTRODUCTION 1 
The discovery of antibiotics is one the main milestones in the history of medicine. 2 
However, excessive overuse of antibiotics has encouraged the emergence of 3 
multidrug-resistant bacteria, leading to a global increase in the spectrum of untreatable 4 
infections, which are currently responsible for around 50,000 annual deaths in Europe 5 
and the United States (Woodford et al., 2011; Blair et al., 2015). There is therefore an 6 
urgent need to identify new antibiotics, but efforts focussed on discovery and 7 
development of new antibiotics have met with only limited success  (Lewis et al., 2013; 8 
Pidot et al., 2014). New platforms for antibiotic discovery include the generation of 9 
synthetic antimicrobials and development of species-specific antibiotics (Fischbach and 10 
Walsh, 2009; Lewis et al., 2013; Liu et al., 2013; Pidot et al., 2014). It has been 11 
estimated that 90% of microbial natural products, and more than 99% of the total 12 
number of secondary metabolites, remain to be discovered. Consequently, recent 13 
approaches to antibiotic discovery include screening of microbes from new ecological 14 
niches and attempts at exploitation of previously uncultured microbes (Fischbach and 15 
Walsh, 2009).    16 
Natural products (and their synthetic derivatives) comprise most of the antibiotics used 17 
clinically (Newman and Cragg, 2007), many of which are based on non-ribosomal 18 
peptides and/or polyketides. Both families of secondary metabolites are synthesised by 19 
multifunctional enzymes, known as non-ribosomal peptide synthetases (NRPSs) and 20 
polyketide synthases (PKSs), through sequential rounds of condensation of amino 21 
acids and acyl-CoA building units, respectively (Sattely et al., 2008; Hertweck, 2009). 22 
The great structural diversity of non-ribosomal peptides and polyketides results from 23 
the number of condensed building units and a range of pre- and post-assembly 24 
processing reactions (Sattely et al., 2008; Hertweck, 2009). This chemical diversity is 25 
consequently reflected in a broad spectrum of biological activities (Sattely et al., 2008; 26 
Fischbach and Walsh, 2009; Hertweck, 2009; Pidot et al., 2014; Mousa and Raizada, 27 
2015). 28 
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Some bacteria can devote up to 10% of their genomes to secondary metabolism 1 
(Udwary et al., 2007; Nett et al., 2009; Chowdhury et al., 2015). The biological 2 
synthesis of such metabolites can be energetically costly and so production is generally 3 
highly regulated (Coulthurst et al., 2005; Williamson et al., 2006; Liu et al., 2013). 4 
Biosynthetic gene clusters are often linked to their own regulatory genes (Chen et al., 5 
2006; Zhao et al., 2010; Gurney et al., 2011; Liu et al., 2013), the products of which are 6 
involved in sensing factors such as physiological state, population density and diverse 7 
environmental cues. As a result, the synthesis of the cognate secondary metabolite can 8 
be modulated appropriately. Quorum sensing regulatory circuits (Coulthurst et al., 9 
2005; Williamson et al., 2006; Müller et al., 2009; Matilla et al., 2015), two-component 10 
systems (Sola-Landa et al., 2003; Haas and Défago, 2005; Williamson et al., 2006), 11 
orphan transcriptional regulators (Williamson et al., 2006; Lu et al., 2011; Klaponski et 12 
al., 2014) and post-transcriptional regulators (Vogel and Luisi, 2011; Romeo et al., 13 
2013) can all be involved in the regulatory complexity of bacterial secondary metabolite 14 
control. 15 
The rhizosphere is one of the most complex environments on earth, with many 16 
organisms interacting and competing for nutrients and space (Lugtenberg and 17 
Kamilova, 2009; Mendes et al., 2013). Many rhizosphere microbes have evolved the 18 
capacity to synthesize bioactive secondary metabolites that allow them to efficiently 19 
antagonize diverse niche competitors (Berg et al., 2002; De Vleesschauwer and Höfte, 20 
2007; Raaijmakers et al., 2009; Pidot et al., 2014; Mousa and Raizada, 2015). 21 
Consequently, this defines the rhizosphere as a habitat with great potential for 22 
exploitation as a source of new natural products with pharmacological, 23 
chemotherapeutic and agricultural applications.  24 
Serratia plymuthica strains are near-ubiquitous in nature but have been commonly 25 
isolated from soil and the rhizosphere of many economically important crops (De 26 
Vleesschauwer and Höfte, 2007). Serratia plymuthica strains possess great potential 27 
as biocontrol agents by antagonizing the growth of plant-pathogens through the 28 
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production of diverse bioactive secondary metabolites, siderophores and lytic enzymes 1 
(Alström, 2001; De Vleesschauwer and Höfte, 2007; Matilla et al., 2015). The strain 2 
used in this study, Serratia plymuthica A153, was isolated from the rhizosphere of 3 
wheat (Ästrom and Gerhardson, 1988) and it has been shown to possess bioactivity 4 
against fungi, oomycetes, bacteria and nematodes (Thaning et al., 2001; Matilla et al., 5 
2012; Hellberg et al., 2015). These activities are mainly due to the synthesis of NRPS- 6 
and PKS-based secondary metabolites, such as the haterumalide, oocydin A (Thaning 7 
et al., 2001), and the polyamine antibiotic, zeamine (Hellberg et al., 2015).   8 
Our previous work showed that the strain A153, in addition to zeamine, produces an 9 
unidentified second antibacterial compound (Hellberg et al., 2015). In this study, we 10 
employed genome sequencing, comparative genomics and mutagenesis approaches 11 
to identify the genes involved in the biosynthesis of the unknown secondary metabolite. 12 
The regulation of the production of the antibacterial compound was also investigated 13 
and the results showed that the expression of the biosynthetic genes is tightly 14 
regulated at transcriptional and post-transcriptional levels. Different environmental cues 15 
controlling the transcription of the biosynthetic genes were also identified.  16 
RESULTS 17 
Serratia plymuthica A153 produces the hybrid nonribosomal peptide-polyketide 18 
antibiotic, andrimid 19 
Characterization of the biocontrol rhizobacterium, S. plymuthica A153, showed that this 20 
strain possesses a strong bioactivity against Bacillus subtilis (Fig. 1A). The observed 21 
antibacterial activity was not associated with the production of other known bioactive 22 
secondary metabolites produced by A153, namely oocydin A (Matilla et al., 2012) or 23 
zeamine (Hellberg et al., 2015).  24 
During the in silico analysis of the A153 genome sequence (Matilla and Salmond, 25 
unpublished data) we identified at least five candidate biosynthetic PKS and NRPS 26 
gene clusters which could be responsible for the synthesis of the unknown antibacterial 27 
6 
 
compound. To identify the genes responsible for this bioactivity, a random transposon 1 
insertion strain library was constructed and screened for mutants defective in 2 
antibacterial activity against Bacillus subtilis. Several transposon insertion mutants 3 
showing loss of antibacterial properties were isolated and all the insertions were 4 
transduced back into the wild type genetic background using the transducing phage 5 
ϕMAM1 (Matilla and Salmond, 2014) to confirm the link between transposon insertions 6 
and mutant phenotype. Random primed PCR confirmed that most of the transposons 7 
were located in a hybrid PKS/NRPS gene cluster described previously as responsible 8 
for the biosynthesis of the broad-spectrum antibiotic, andrimid (Fig. 1 and S1; Jin et al., 9 
2006). 10 
We had access to another plant-associated oocydin A producing strain, Serratia 11 
marcescens MSU97. This strain also showed strong antibacterial activity towards B. 12 
subtilis (Fig. S2) and sequencing of its genome (Matilla and Salmond, unpublished 13 
data) revealed that the andrimid (adm) gene cluster is also present in this plant 14 
epiphytic bacterium (Fig. S3). We reported previously that MSU97 is recalcitrant to 15 
various genetic tools (Matilla et al., 2012) and attempts at isolating mutants defective in 16 
the adm gene cluster of this strain were unsuccessful.	 17 
Comparative analyses of sequenced andrimid gene clusters 18 
The biosynthesis of andrimid has been demonstrated in a broad range of bacteria 19 
(Fredenhagen et al., 1987; Long et al., 2005; Jin et al., 2006; Wietz et al., 2011; 20 
Sánchez et al., 2013). However, few adm gene clusters have been sequenced, 21 
including those of the marine bacteria, Vibrionales SWAT-3 (PATRIC Genome ID 22 
391574.12) and Vibrio coralliilyticus S2052 (Machado et al, 2015), and the plant-23 
associated enterobacterium Pantoea agglomerans Eh335 (Jin et al., 2006; GenBankTM 24 
accession no. AY192157.1). Additionally, our genomic analyses revealed that the adm 25 
gene cluster is also present in the recently sequenced rhizobacterium Serratia 26 
marcescens 90-166 (Fig. S3 and S4; Jeong et al., 2015).  27 
7 
 
Comparative analyses showed that the genomic context of the sequenced adm gene 1 
clusters in A153, MSU97, Eh335, S2052 and SWAT-3 is completely different and, 2 
consequently, the upstream and downstream predicted ends of the biosynthetic 3 
clusters were assigned based only on their homologies (Fig. S3 and S4). These 4 
analyses allowed the identification of a gene, designated admV, located immediately 5 
upstream of admA. AdmV was not previously associated with andrimid biosynthesis 6 
(Jin et al., 2006) and in silico analyses did not shed light on its putative function. 7 
However, we found that the gene admV is conserved in all adm gene clusters (Fig. S3 8 
and S4). To further investigate its role in the synthesis of andrimid, we constructed an 9 
in frame deletion mutant defective in admV, thereby avoiding polar effects in the 10 
expression of the downstream adm genes. The resulting mutant strain no longer 11 
exhibited antibacterial activity and the bioactivity could be complemented by the in-12 
trans expression of AdmV (Fig. 2).  13 
The adm gene clusters of A153, MSU97, 90-166, Eh335, SWAT-3 and S2052 are 25.1, 14 
24.9, 24.8, 24.7, 25.6 and 25.6-kb respectively, and they are between 70.1% and 15 
99.0% identical at the DNA level (Fig. S4 and Table S1) suggesting that adm 16 
biosynthetic clusters may have been moved horizontally between the producing strains. 17 
In accordance with this hypothesis, the overall genomic G + C content of A153 18 
(56.0%), MSU97 (58.9%), 90-166 (59.1%), SWAT-3 (44.5%) and S2052 (45.7%) is 19 
considerably different from the G + C content of their respective adm biosynthetic 20 
clusters, which are 45.8%, 47.6%, 46.27, 51.1% and 51.2%, respectively. Furthermore, 21 
remnant sequences of transposable genetic elements were found flanking the gene 22 
clusters of all the producing strains, although located in different regions in these loci 23 
(Fig. S3).  24 
In contrast, some remarkable differences were found between the six biosynthetic 25 
clusters. First, the intergenic regions of several adm contiguous genes are not 26 
conserved between the adm gene clusters (Fig. S4) which could suggest differential 27 
regulation in the expression of the biosynthetic clusters. Second, the intergenic region 28 
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between admS and admT is considerably larger in A153, MSU97 and 90-166, and we 1 
identified a putative ORF, admW, in these three Serratia strains (Fig. S3 and S4). 2 
However, the in frame deletion of admW did not alter the antibacterial activity of A153 3 
(Fig. 1A). Finally, a gene encoding a LysR-type transcriptional regulator was found 4 
upstream of admT in the adm gene clusters of Vibrionales SWAT-3 and Vibrio 5 
coralliilyticus S2052 (Fig. S3).  6 
The andrimid gene cluster consists of a large polycistronic unit	7 
The adm gene cluster in Serratia consists of 22 predicted ORFs and its genetic 8 
organization, together with the small intergenic distances between contiguous genes, 9 
suggests the presence of a single transcriptional unit (Fig. 3A and S3). To further 10 
understand the biosynthesis of andrimid, we investigated its transcriptional regulation. 11 
With primers spanning the 3´ end of the upstream gene and the 5´ end of the 12 
contiguous downstream gene (Fig. 3A), we used reverse transcription-PCR (RT-PCR) 13 
to assess co-transcription of the adm genes in S. plymuthica A153. PCR products were 14 
obtained across all intergenic regions covering the complete adm biosynthetic cluster, 15 
indicating the presence of one long polycistronic transcript (Fig. 3B) - although the 16 
possibility of internal promoters cannot be discarded.  17 
The transcription of the adm biosynthetic cluster is growth phase dependent 18 
We identified several mutants in which the Tn-KRCPN1 transposon generated β-19 
galactosidase transcriptional fusions (Table 1). Because our RT-PCR analyses 20 
demonstrated the presence of an operonic adm biosynthetic cluster, we investigated 21 
transcription throughout growth in a Lac- derivative of A153. Using a chromosomal 22 
fusion located in the first multidomain PKS/NRPS-encoding gene of the biosynthetic 23 
cluster (admK) our β-galactosidase assays showed that the transcription of the adm 24 
operon started in late-logarithmic phase of growth (Fig. 4A and Fig. 5B). Expression of 25 
the biosynthetic cluster correlated perfectly with the presence of andrimid in cell-free 26 
supernatants (Fig. 4B).   27 
9 
 
Temperature and carbon source regulate the transcription of the adm operon 1 
The biosynthesis of secondary metabolites can be energetically costly and other 2 
secondary metabolites produced by Serratia strains have been shown to be highly 3 
regulated by various environmental cues (Williamson et al., 2005; Coulthurst et al., 4 
2006). To shed light on the regulation of andrimid production in A153, we investigated 5 
the impact of different environmental parameters in the transcription of the adm operon. 6 
At the optimal growth temperature (30 ºC) for A153, andrimid production was abolished 7 
(Fig. 5A). However, as the temperature decreased, a gradual increase in the 8 
production of andrimid was observed, with higher production levels at 15 ºC than at 25 9 
ºC (Fig. 5A). To examine whether the increase in andrimid production was reflected in 10 
the expression of the adm gene cluster, we evaluated the impact of temperature on the 11 
transcription of the biosynthetic cluster. β-galactosidase assays showed that the 12 
transcription was also thermoregulated (Fig. 5B). In accordance with this, no adm 13 
expression was observed at temperatures above 30 ºC, confirming the tight correlation 14 
between andrimid production and transcription of the biosynthetic operon (Fig. 5B).  15 
Serratia plymuthica A153 was originally isolated from the rhizosphere (Astrom and 16 
Gerhardson, 1988), a soil environment which is under the direct influence of plant-root 17 
exudates. The composition of root exudates is chemically complex but quantitatively it 18 
consists mainly of carbon-based compounds, primarily organic acids and sugars (Uren, 19 
2007; Badri and Vivanco, 2009; Suzuki et al., 2009). Thus, we investigated the 20 
production of andrimid in response to different carbon sources found in plant root 21 
exudates. Our results showed that andrimid is differentially produced depending on 22 
carbon source. Maximal antibacterial activity was observed in the presence of citrate, 23 
gluconate or glycerol whereas no activity was detected in the presence of arabinose or 24 
succinate as sole carbon sources (Fig. 6A). Although the growth rates of A153 varied 25 
between the tested carbon sources (Fig. S5), the observed antibacterial activity was 26 
not correlated with the growth rate per se or the final optical density reached in each of 27 
the culture media. Consistent with these observations, higher transcriptional levels of 28 
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the adm operon were observed in media containing citrate or gluconate, whereas no 1 
transcription was seen in arabinose media (Fig. 6B), confirming that both transcriptional 2 
activity and andrimid production, were carbon source-dependent. 3 
Finally, we also evaluated the production of andrimid at different pH, aeration 4 
conditions and NaCl concentrations, but no impacts on antibacterial synthesis were 5 
observed (not shown). 6 
The LysR-type regulator, AdmX, activates andrimid production. 7 
Analysis of the genomic context of the adm gene clusters in A153, MSU97, 90-166, 8 
Eh335, S2052 and SWAT-3 revealed a 2-kb region upstream of admV which was 9 
highly conserved in the Serratia strains (Fig. S3 and S4). This region contained a gene 10 
encoding a putative LysR-type transcriptional regulator (LTTR; Fig. S3 and S4). The 11 
family of LTTRs comprises one of the largest classes of transcriptional regulators in 12 
bacteria, functioning either as repressors or activators of the transcription of their target 13 
genes (Maddocks and Oyston, 2008). To investigate the potential role of the identified 14 
LTTR in andrimid biosynthesis, we engineered an in frame deletion mutant in S. 15 
plymuthica A153. The resulting mutant did not inhibit growth of B. subtilis but 16 
antibacterial activity was fully restored by in trans expression of the LTTR encoding 17 
gene (Fig. 7A). These results suggested that the regulator, designated AdmX, is 18 
responsible for activating transcription of the adm gene cluster and β-galactosidase 19 
assays confirmed that expression of the biosynthetic cluster was abolished in an 20 
admX-deficient strain (Fig. 4A). These results were supported by qPCR analyses 21 
showing decreased adm transcript levels in the A153 ∆admX strain (Fig. S6).  22 
To assess the transcription of admX throughout growth, we constructed a 23 
transcriptional fusion of the admX promoter to the reporter gene lacZ. β-galactosidase 24 
assays showed that the transcription of admX started in late-logarithmic phase of 25 
growth, correlating with transcription of the adm biosynthetic cluster. We explored the 26 
effect of AdmX on expression of its cognate gene. However, the transcription of admX 27 
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remained unaltered in an admX mutant strain (Fig. S7). Finally, we also investigated 1 
whether andrimid thermoregulation is mediated by AdmX. Previous studies showed 2 
that the expression of another LTTR (PecT), and consequently the expression of its 3 
target genes, is thermoregulated (Hérault et al., 2014). However, no differences in 4 
transcripts levels of admX were observed (using qPCR analysis) at 25, 30 and 37 ºC 5 
(data not shown). 6 
The chaperone Hfq regulates the expression of the adm gene cluster  7 
The biosynthesis of secondary metabolites is frequently regulated at post-8 
transcriptional level and, in gammaproteobacteria, this is mainly mediated by the 9 
Csr/Rsm (Romeo et al., 2013) and Hfq (Vogel and Luisi, 2011) systems. To assess a 10 
potential role of these post-transcriptional regulatory systems, we analyzed the 11 
production of andrimid in different genetic backgrounds in S. plymuthica A153. A 12 
mutant with a deletion in the non-coding sRNA, csrB, showed the same antibacterial 13 
activity as the wild type strain (not shown). However, in frame deletion of hfq led to 14 
complete loss of andrimid production (Fig. 7B) and this phenotype was partially 15 
complemented by the in trans expression of hfq (Fig. S8).  16 
β-galactosidase assays were performed to assess the expression of the adm gene 17 
cluster throughout growth in A153 ∆hfq. The results showed that transcription of the 18 
andrimid operon was abolished in a hfq-deficient strain, indicating that the chaperone 19 
Hfq positively regulates expression of the adm biosynthetic cluster (Fig. 4A). qPCR 20 
analyses confirmed that the transcriptional levels of the adm gene cluster were reduced 21 
by 99.9% in an hfq-deficient background (Fig. S6). To investigate whether Hfq 22 
regulates admX expression, qPCR experiments were also performed. However, admX 23 
transcript levels were unaltered in the ∆hfq mutant (Fig. S6). 24 
The expression of the adm gene cluster starts in late-logarithmic phase of growth (Fig. 25 
4) and so we investigated whether quorum sensing (QS) could be regulating andrimid 26 
production. A153 carries sptI, sptR, splR and spsR genes encoding LuxI- and LuxR-27 
12 
 
type proteins very similar to those of the three QS systems identified in the 1 
taxonomically related rhizobacterium, S. plymuthica G3 (Liu et al., 2011; Duan et al., 2 
2012). However mutations in each of these four genes in A153 had no observable 3 
impacts on antibacterial activity (not shown). Similarly, the role of the stationary phase 4 
sigma factor, RpoS, in the production of andrimid was also investigated, but the 5 
antibacterial activity of an rpoS mutant was indistinguishable from that of the wild type 6 
strain (Fig. 7B).  7 
DISCUSSION 8 
Since the golden age of antimicrobial discovery in the 1940-60s, there has been a 9 
diminution in the rate of discovery of new antibiotics and this problem has been 10 
exacerbated by the progressive emergence worldwide of antibiotic-resistant bacteria 11 
(Lewis, 2013; Blair et al., 2015). However, there are many antibiotics described in the 12 
literature that, although not currently exploited, could prove to be lead molecules for 13 
drug discovery programmes leading to clinical or agricultural utility. The hybrid 14 
NRPS/PKS antibacterial compound, andrimid, was first isolated in the late 1980s from 15 
a brown planthopper intracellular symbiont belonging to the Enterobacter genus 16 
(Fredenhagen et al., 1987). After its discovery, three related antibacterial compounds, 17 
moiramides A-C (Fig. S1), were also isolated from Pseudomonas fluorescens 18 
(Needham et al., 1994).  19 
Andrimid is a nanomolar inhibitor of the bacterial acetyl-CoA carboxylase (Freiberg et 20 
al., 2004), an enzyme responsible for the conversion of acetyl-CoA to malonyl-CoA in 21 
the first committed step for the synthesis of fatty acids (Harwood, 2007). The discovery 22 
of the andrimid target, together with its unusual chemistry, has stimulated interest in the 23 
biochemistry and genetics of the antibiotic. The andrimid gene cluster was first 24 
described almost a decade ago and a model for its biosynthesis proposed (Jin et al., 25 
2006). In this model, the function for most of the Adm proteins was predicted and, in 26 
some cases, later demonstrated biochemically (Fortin et al., 2007; Magarvey et al., 27 
13 
 
2008; Ratnayake et al., 2011). However, the roles of the hypothetical proteins AdmB, 1 
AdmL and AdmN in the synthesis of andrimid remain unknown. In this study, we 2 
redefined the length of the adm gene cluster by identifying a new hypothetical protein 3 
encoding gene, admV, located immediately upstream of admA and forming part of the 4 
adm operon (Fig. 3 and S3). Using mutagenesis and complementation analyses we 5 
demonstrated that AdmV is required for the biosynthesis of andrimid. Our bioinformatic 6 
analyses did not categorically clarify the function of AdmV. However, in silico studies 7 
predicted three alpha helices with a high content of positively charged amino acids at 8 
the C-terminal end, suggesting that AdmV may be a DNA binding protein. 9 
Andrimid has been shown to be a broad-spectrum antibacterial compound that acts on 10 
Gram-positive and Gram-negative bacteria. It was first isolated after it was shown to 11 
have potent activity against the different pathovars of the phytopathogen, 12 
Xanthomonas campestris (Fredenhagen et al., 1987) but further research showed that 13 
it is also active against bacterial pathogens belonging to Bacillus, Enterococcus, 14 
Escherichia, Salmonella, Staphylococcus, Vibrio and Yersinia genera (Needham et al., 15 
1994; Singh et al. 1997; Long et al., 2005, Wietz et al., 2010, Sánchez et al., 2013). 16 
Resistance to andrimid is dependent on multidrug efflux pumps (Freiberg et al., 2004; 17 
Jin et al., 2006) or the presence of andrimid-resistant acetyl-CoA carboxyltransferases 18 
(ACC) hypothesized to show decreased affinity for the inhibitor (Liu et al., 2008). 19 
Interestingly, we showed that the plant-pathogen Agrobacterium tumefaciens and 20 
multiple rhizobacteria strains in the family Enterobacteriaceae (i.e. Kluyvera, Pantoea, 21 
Serratia, Weeksella, Xenorhabdus, and the emerging phytopathogen, Dickeya solani) 22 
(Fig. S9 and S10) are sensitive to andrimid. However, the differential sensitivities to the 23 
antibiotic of these plant-associated strains could also indicate the presence of weaker 24 
intrinsic resistance mechanism(s) of different efficiencies.  25 
NRPS and PKS constitute the main enzymatic source of secondary metabolites in 26 
bacteria; 36% of which are generated by hybrid NRPS/PKS gene clusters (Wang et al., 27 
2014). Secondary metabolites have been associated with important roles in the 28 
14 
 
physiology and development of the bacterial host, but are also implicated in 1 
overcoming competitors in the same nutritional niche (Liu et al., 2013; Pidot et al., 2 
2014; Wang et al., 2014; Mousa and Raizada, 2015). The synthesis in situ of andrimid 3 
has been demonstrated in a sponge-associated bacterium (Oclarit et al., 1994; Long et 4 
al., 2005) and its production is favoured over that of other metabolites in conditions 5 
mimicking natural environments - suggesting an important ecophysiological role of 6 
andrimid (Wietz et al., 2011). Consistent with this view, even sub-lethal concentrations 7 
of andrimid can promote a negative chemotactic response (in sensitive competitors) 8 
away from the antibiotic, thereby enhancing competitiveness of the producers (Graff et 9 
al., 2013). In S. plymuthica A153, the synthesis of andrimid is carbon source-10 
dependent and induced in the presence of sugars and organic acids commonly found 11 
in plant root exudates (Fig. 6).  Carbon source has been shown to regulate antibiotic 12 
synthesis at both molecular and physiological levels and, in general, rapidly 13 
metabolized carbon sources are involved in repression of bacterial secondary 14 
metabolites (Sánchez et al., 2010). However, our results did not show a correlation 15 
between preferred carbon sources and andrimid production (Fig. 6 and S5). 16 
Importantly, in A153, the production of the antibiotic zeamine is high in the presence of 17 
carbon sources which show low andrimid production (i.e. arabinose, sorbitol, succinate) 18 
whereas the synthesis of zeamine is repressed by carbon sources that stimulate 19 
andrimid production (i.e. citrate, gluconic acid, glycerol) (Fig. 6; Hellberg et al., 2015). 20 
This “mirror image” metabolic regulation of andrimid and zeamine production when 21 
presented with different environmental carbon sources could be beneficial in 22 
maintaining the capacity of A153 to overcome bacterial competitors in its natural niche, 23 
the rhizosphere, where specific carbon source availability is likely to fluctuate.  24 
Soil bacteria are subjected to daily and seasonal abiotic variations and temperature is 25 
considered a key abiotic factor influencing bacterial metabolic activity - which may 26 
therefore modulate inter- and intra-specific interactions between microbes. The results 27 
reported here show that andrimid synthesis in A153 is thermoregulated, with enhanced 28 
15 
 
antibiotic production at lower temperature. Previous studies also showed that andrimid 1 
production in Vibrio (Long et al., 2005; Wietz et al., 2011) and Serratia strains 2 
(Sánchez et al., 2013) is also thermosensitive. In this study, we demonstrate that the 3 
observed thermoregulation is exerted at the transcriptional level (Fig. 5) and in a 4 
AdmX-independent fashion. During the analysis of the bioactive properties of A153, we 5 
showed that the production of the haterumalide, oocydin A, is also thermosensitive 6 
(Matilla and Salmond, unpublished) and this may indicate that a common control 7 
pathway is modulating the thermoregulation of the biosynthesis of secondary 8 
metabolites in A153. The ecological role of this thermosensitivity is unknown, although 9 
it could be related to competitiveness and efficient colonization of specific niches by the 10 
producing rhizobacterium, S. plymuthica A153. 11 
To date, most of the published research on andrimid has focussed on its biochemistry, 12 
but the regulation of its biosynthesis has attracted little attention. The first adm gene 13 
cluster was identified in Pantoea agglomerans but no regulatory proteins were found in 14 
this biosynthetic cluster (Jin et al., 2006). However, our analysis of the genomic context 15 
of the andrimid gene cluster in A153, MSU97 and 90-166, revealed a LysR-type 16 
regulator-encoding gene, admX, which was highly conserved in these producing strains 17 
(Fig. S3 and S4). Mutagenesis, complementation and gene expression analyses 18 
demonstrated that AdmX is a positive regulator of andrimid biosynthesis (Fig. 4 and 19 
7A). AdmX is a 305 amino acid protein composed of a helix-turn-helix motif-containing 20 
DNA-binding domain and a probable effector binding domain at the N-terminal and C-21 
terminal regions, respectively (Fig. S11). By analogy with other LTTR structures 22 
(Ezezika et al., 2007; Monferrer et al., 2010 ; Devesse et al., 2011), AdmX is proposed 23 
to possess a potential effector binding site located in between the two lobes of the 24 
effector binding domain (Fig. S11). Inspection of a homology model shows that this site 25 
is primarily composed of amino acids with hydrophobic side chains (Fig. S11) and 26 
further investigations are necessary to identify candidate effector molecules.  27 
16 
 
In general, LysR transcriptional regulators activate the expression of their target genes 1 
while negatively autoregulating their own transcription (Maddocks and Oyston, 2008). 2 
LTTRs have been shown to regulate genes involved in metabolism, virulence, motility, 3 
chemotaxis, quorum sensing and biofilm formation (Maddocks and Oyston, 2008). 4 
However, only a limited number of LTTRs have been found to regulate the biosynthesis 5 
of secondary metabolites - such as actinorhodin (Mao et al., 2013), phenazines 6 
(Klaponski et al., 2014), pyoluteorin (Li et al., 2012), ralfuranones (Kai et al., 2014) and 7 
undecylprodigiosin (Mao et al., 2013). LTTRs are broadly distributed within the 8 
prokaryotic kingdom, suggesting dissemination and acquisition by horizontal gene 9 
transfer (HGT; Maddocks and Oyston, 2008). In accordance with this notion, 10 
sequences reminiscent of transposases were found flanking admX (Fig. S3 and S4) 11 
and the G + C content of the admX genes in A153, MSU97 and 90-166 is considerably 12 
higher than that of their respective adm gene clusters. Although AdmX seems to be 13 
restricted to the adm biosynthetic clusters present in Serratia strains, BLAST analyses 14 
showed that AdmX is up to 84% identical (90% similar) to an orphan LysR-type 15 
regulator highly conserved within Enterobacter and Klebsiella genera, again suggesting 16 
that this LTTR-encoding gene may have been acquired by HGT. Interestingly, we 17 
found an LTTR-encoding gene immediately upstream of admT in the adm gene 18 
clusters of Vibrio coralliilyticus S2052 and Vibrionales SWAT-3 (Fig. S3), perhaps 19 
indicating an important regulatory role in the expression of the adm gene clusters in 20 
these strains. It has been proposed that the fragmented andrimid biosynthetic pathway 21 
reflects a recent evolutionary origin (Magarvey et al., 2008) and so the insertion of the 22 
LTTR-encoding genes in the adm gene clusters of Vibrio and Serratia may represent a 23 
step forward in the evolution of these biosynthetic clusters. 24 
The post-transcriptional regulation of the adm gene cluster in A153 was also 25 
investigated and our results showed that the RNA binding protein, Hfq, positively 26 
regulates the expression of the andrimid operon. Previous studies of Serratia strains 27 
showed that the synthesis of secondary metabolites such as a carbapenem antibiotic 28 
17 
 
(Wilf et al., 2011), prodigiosin (Wilf et al., 2011) and pyrrolnitrin (Zhou et al., 2012) is 1 
regulated by Hfq, and we recently showed that Hfq positively regulates the expression 2 
of the oocydin A (Matilla et al., 2015) and zeamine (Hellberg et al., 2015) gene clusters 3 
in S. plymuthica A153. It is known that Hfq also stimulates rpoS translation (Vogel and 4 
Luisi, 2011) and the deletion of hfq results in reduced rpoS transcripts levels in A153 5 
(Matilla et al., 2015). However, contrary to our observations on regulation of oocydin A 6 
in A153 (Matilla et al., 2015), Hfq-mediated regulation of andrimid is independent of 7 
RpoS (Fig. 7B), as observed in other Serratia strains for the biosynthesis of zeamine 8 
(Hellberg et al., 2015), carbapenem (Wilf and Salmond, 2012) and prodigiosin (Wilf and 9 
Salmond, 2012) antibiotics. 10 
In summary, we have shown that the plant-associated bacterium, Serratia plymuthica 11 
A153 produces the broad spectrum antibacterial compound, andrimid. Comparative 12 
genomics, molecular genetics and transcriptional approaches led us to re-define the 13 
borders of the adm gene clusters and identify new genes involved in the biosynthesis 14 
and regulation of andrimid. Further, in vivo assays expanded the spectrum of bacterial 15 
strains which are sensitive to andrimid. For the first time, the regulation of the 16 
biosynthesis of andrimid was investigated at transcriptional and post-transcriptional 17 
levels. Future research will provide information about the effectors recognized by 18 
AdmX and such knowledge, coupled with the work described in this study, may 19 
encourage the use of plant-associated andrimid-producing strains as biocontrol agents 20 
in sustainable agriculture strategies. 21 
EXPERIMENTAL PROCEDURES 22 
Bacterial strains, culture media and growth conditions 23 
Bacterial strains used in this study are listed in Table 1 and S2. Serratia, Bacillus, 24 
Agrobacterium, Dickeya, Kluyvera, Pantoea, Weeksella, Xanthomonas, Xenorhabdus, 25 
Yersinia and their derivative strains were grown routinely at 30 ºC, unless otherwise 26 
indicated, in Luria Broth (LB; 5 g yeast extract l-1,10 g Bacto tryptone l-1 and 5 g NaCl l-27 
18 
 
1) or minimal medium (0.1%, w/v, (NH4)2SO4, 0.41 mM MgSO4, 40 mM K2HPO4, 14.7 1 
mM KH2PO4, pH 6.9–7.1) with glucose (0.2%; w/v) as carbon source, unless otherwise 2 
indicated. Escherichia coli strains were grown at 37 °C in LB. Escherichia coli DH5α 3 
was used as a host for gene cloning. Media for propagation of E. coli β2163 were 4 
supplemented with 300 µM 2,6-diaminopimelic acid. When appropriate, antibiotics were 5 
used at the following final concentrations (in µg ml-1): ampicillin, 100; chloramphenicol, 6 
25; kanamycin, 25 (E. coli strains) and 50 (Serratia strains); streptomycin, 50; 7 
tetracycline, 10. Sucrose was added to a final concentration of 10% (w/v) when 8 
required to select derivatives that had undergone a second crossover event during 9 
marker-exchange mutagenesis. Bacterial growth (OD600 nm) was measured on a 10 
Unicam Heλios spectrophotometer at 600 nm, 1 cm path length. 11 
In vitro nucleic acid techniques and bioinformatic analyses 12 
Plasmid DNA was isolated using the Anachem Keyprep plasmid kit. For DNA digestion, 13 
the manufacturer’s instructions were followed (New England Biolabs, Roche and 14 
Fermentas). Separated DNA fragments were recovered from agarose gels using the 15 
Anachem gel recovery kit. Ligation reactions and total DNA extraction were performed 16 
as previously described (Sambrook et al., 1989). Competent cells were prepared using 17 
calcium chloride and transformations were performed by standard protocols (Sambrook 18 
et al., 1989). Phusion® high fidelity DNA polymerase (New England Biolabs) was used 19 
in the amplification of PCR fragments for cloning. PCR reactions were purified using 20 
the Anachem PCR Clean-up kit. PCR fragments were verified by DNA sequencing that 21 
was carried out at the University of Cambridge DNA Sequencing Facility (Cambridge, 22 
United Kingdom) or at the Institute of Parasitology and Biomedicine Lopez-Neyra 23 
(CSIC; Granada, Spain). Sequence comparison analyses were performed employing 24 
the wgVISTA online tool (Frazer et al., 2004). Open reading frames (ORFs) in the 25 
andrimid gene clusters were predicted using Glimmer 3.0 (Delcher et al.,1999). Blast 26 
analyses were used for the functional gene assignment. Protein domain organization 27 
was identified using the NCBI conserved domains database. Multiple sequence 28 
19 
 
alignments were carried out with ClustalW2 (European Bioinformatics Institute). 1 
Artemis software (Wellcome Trust Sanger Institute) was used to visualize genomic 2 
sequences. 3 
Random Transposon Mutagenesis 4 
Random transposon mutagenesis of S. plymuthica A153 using Tn-KRCPN1 was 5 
performed by biparental conjugation mating using Escherichia coli β2163, as described 6 
previously (Matilla et al., 2012). In total, three thousand kanamycin-resistant insertion 7 
mutants were screened for their antibacterial activity against Bacillus subtilis using dual 8 
drop culture bioassays. Auxotrophic mutants were discarded and insertion mutations 9 
were transduced into the wild type strain A153 using phage ϕMAM1 (Matilla and 10 
Salmond, 2014). The insertion site of transposon Tn-KRCPN1 in mutants of interest 11 
was determined using random primed PCR following the method described previously 12 
(Matilla et al., 2012) and using primers described in supplemental Table S3. 13 
Antibacterial assays 14 
Antibiotic activity was tested using agar lawn assays. Briefly, indicator plates for 15 
andrimid production contained a 0.8% LB agar (LBA) top lawn containing 200 µl of an 16 
overnight culture of the bacterial strain to test. Five microliters of overnight cultures of 17 
the andrimid-producing strains were spotted on the surface of the indicator agar lawn 18 
and incubated for 48 h at 25 °C, unless otherwise indicated. To determine andrimid 19 
levels in bacterial supernatants, culture samples were taken, bacterial cells were 20 
pelleted by centrifugation (10,000 x g, 10 min), and the supernatant was filtered (0.2 21 
µm). Three hundred microliters of the filter-sterilized supernatant were added to wells 22 
cut into the LBA plate and incubated at 25 °C for 24 h. All experiments were repeated 23 
at least three times. 24 
Construction of strains and plasmids 25 
Chromosomal mutants of Serratia plymuthica strains were constructed by homologous 26 
recombination using derivative plasmids of the suicide vector pKNG101. These 27 
plasmids, which are listed in Table S4, were confirmed by DNA sequencing and they 28 
20 
 
carried mutant in-frame deletions for the replacement of wild type genes in the 1 
chromosome. Primers used in this study are listed in Table S3. In all cases, plasmids 2 
for mutagenesis were transferred to S. plymuthica strains by triparental conjugation 3 
using E. coli CC118λpir and E. coli HH26 (pNJ500) as helper. The plasmids for the 4 
construction of the in-frame deletion mutants were generated by amplifying the up- and 5 
downstream flanking regions of the gene, or domain to be deleted. The resulting PCR 6 
products were digested with the enzymes specified in Table S4 and ligated in a three-7 
way ligation into pUC18Not, previously cloned into the marker exchange vector 8 
pKNG101. The in-frame deletion mutant strains ANDX, ANDV and ANDW were 9 
generated using plasmids pMAMV175, pMAMV191 and pMAMV192, respectively. 10 
Mutant strains defective in hfq, A153H and A153HL, were constructed using plasmid 11 
pMAMV193. All relevant mutations were confirmed by PCR and sequencing.  12 
For the construction of the complementing plasmids, the genes were amplified using 13 
primers described in Table S3 and cloned into pTRB30. All the inserts were confirmed 14 
by PCR and sequencing. Complementing plasmids were used to transform A153 by 15 
electroporation. 16 
Genetic complementation assays 17 
Complementation of mutations was carried out by the introduction of a wild type copy 18 
of the corresponding mutated gene in trans on plasmid pTRB30. For the 19 
complementation assays, LBA containing the appropriate antibiotic (to maintain the 20 
plasmid) and isopropyl-β-D-thiogalactopyranoside (IPTG) at 0.1 or 1 mM were added to 21 
holes punched in Bacillus subtilis bioassay plates. Then, 5 μl of overnight cultures of 22 
the selected strains were spotted on the surface of the LBA containing the antibiotic 23 
and IPTG and were incubated at 25 °C for 2 days. 24 
Generalized Transduction 25 
The generalized transducing viunalikevirus, ϕMAM1, was used for transduction of 26 
chromosomal mutations, as described previously (Matilla and Salmond, 2014). 27 
β-Galactosidase assays 28 
21 
 
Expression of the lacZ reporter gene was performed using the fluorogenic substrate 4-1 
methylumbelliferyl β-D-galactoside (Melford Cat No. M1095) at a final concentration of 2 
0.125 mg ml−1, as described previously (Ramsay, 2013). Samples were measured in a 3 
SpectraMax Gemini XPS fluorescence microplate reader (Molecular Devices) using the 4 
following settings: excitation 360 nm, emission 450 nm, cut-off 435 nm, reading every 5 
30 s for 20 min at 37°C. β-Galactosidase activity was expressed as relative fluorescent 6 
units s–1 and normalize to the OD600 nm of the corresponding sample. Alternatively, β-7 
galactosidase activity was measured as described previously (Miller, 1972) using 2-8 
Nitrophenyl β-D-galactopyranoside (ONPG; Sigma-Aldrich Cat No. N1127) as 9 
substrate. All the transcriptional fusion assays were carried out using S. plymuthica 10 
A153 LacZ (control) or derived mutants. 11 
RNA extraction, cDNA synthesis, Reverse Transcription-PCR (RT-PCR) and 12 
quantitative real time PCR analyses 13 
RNA was extracted from early stationary phase cultures grown in LB medium using an 14 
RNeasy mini kit (Qiagen) according to the manufacturer’s instructions. RNA 15 
concentration was determined spectrophotometrically and RNA integrity was assessed 16 
by agarose gel electrophoresis. Genomic DNA contamination was eliminated by 17 
treating total RNA with Turbo DNA-free (Ambion). The synthesis of cDNA was 18 
performed using random hexamers (GE Healthcare) and SuperScript II reverse 19 
transcriptase (Invitrogen) in a 30 µl reaction with 2 µg of total RNA and incubation at 42 20 
°C for 2 h. As negative control the reaction was performed omitting the reverse 21 
transcriptase. For the RT-PCR analysis, the equivalent of 50 ng of total RNA was 22 
subjected to PCR amplification using primers to amplify across the junctions (Table 23 
S3). Positive and negative control PCR reactions were performed using genomic DNA 24 
and no-RT cDNA samples, respectively, as templates. PCR conditions consisted of 30 25 
cycles of denaturation for 1 min at 94 °C, annealing for 1 min at 62 °C, and extension 26 
for 40 s at 72 °C. qPCRs were performed as described previously (Burr et al., 2006) 27 
using primers specific for admX and admV (Table S3). qPCR amplifications were 28 
22 
 
performed using an MyiQTM2 Two-Color Real-Time PCR Detection System (Bio-Rad). 1 
To confirm the absence of contaminating genomic DNA, control PCRs were carried out 2 
using no RT cDNA samples as templates. Melting curve analyses were conducted to 3 
ensure amplification of a single product. The relative gene expression was calculated 4 
using the critical threshold (∆∆Ct) method (Pfaffl, 2001) and using 16S rRNA as the 5 
internal control to normalize the data. 6 
ACKNOWLEDGEMENTS 7 
We thank Kornelia Smalla and Ian Toth for the generous donation of bacterial strains. 8 
Work in the Salmond laboratory is supported by funding through the Biotechnology and 9 
Biological Sciences Research Council (UK). M.A.M. was supported by the EU Marie-10 
Curie Intra-European Fellowship for Career Development (FP7-PEOPLE-2011-IEF) 11 
Grant No. 298003 and the Spanish Ministry of Economy and Competitiveness 12 
Postdoctoral Research Program, Juan de la Cierva (BVA-2009-0200). The Krell 13 
laboratory is supported by FEDER funds and Fondo Social Europeo through grants 14 
from the Junta de Andalucía (grant CVI-7335) and the Spanish Ministry for Economy 15 
and Competitiveness (grants BIO2013-42297 and RTC-2014-1777-3). 16 
	17 
REFERENCES 18 
- Alström, S. (2001) Characteristics of bacteria from oilseed rape in relation to their 19 
biocontrol activity against Verticillium dahliae. J Phytopathology 149: 57-64. 20 
- Åström, B., and Gerhardson, B. (1988). Differential reactions of wheat and pea 21 
genotypes to root inoculation with growth-affecting rhizosphere bacteria. Plant Soil 109: 22 
263-269. 23 
- Badri, D.V., and Vivanco, J.M. (2009) Regulation and function of root exudates. 24 
Plant Cell Environ 32: 666-81.  25 
23 
 
- Berg, G., Roskot, N., Steidle, A., Eberl, L., Zock, A., and Smalla, K. (2002) Plant-1 
dependent genotypic and phenotypic diversity of antagonistic rhizobacteria isolated 2 
from different Verticillium host plants. Appl Environ Microbiol 68: 3328-3338. 3 
- Blair, J.M., Webber, M.A., Baylay, A.J., Ogbolu, D.O., and Piddock, L.J. (2015) 4 
Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 13: 42-51. 5 
- Burr, T., Barnard, A.M., Corbett, M.J., Pemberton, C.L., Simpson, N.J., and 6 
Salmond, G.P.C. (2006) Identification of the central quorum sensing regulator of 7 
virulence in the enteric phytopathogen, Erwinia carotovora: the VirR repressor. Mol 8 
Microbiol 59: 113–125. 9 
- Chen, X.H., Vater, J., Piel, J., Franke, P., Scholz, R., Schneider, K., et al. (2006) 10 
Structural and functional characterization of three polyketide synthase gene clusters in 11 
Bacillus amyloliquefaciens FZB42. J Bacteriol 188: 4024–4436. 12 
- Chowdhury, S.P., Hartmann, A., Gao, X., and Borriss, R. (2015) Biocontrol 13 
mechanism by root-associated Bacillus amyloliquefaciens FZB42 - a review. Front 14 
Microbiol 6: 780.  15 
- Coulthurst, S.J., Barnard, A.M., and Salmond, G.P.C. (2005) Regulation and 16 
biosynthesis of carbapenem antibiotics in bacteria. Nat Rev Microbiol 3: 295–306. 17 
- De Vleesschauwer, D., and Hofte, M. (2007) Using Serratia plymuthica to control 18 
fungal pathogens of plants. CAB Reviews: Perspectives in Agriculture, Veterinary 19 
Science, Nutrition and Natural resources 2: 1-12. 20 
- Delcher, A.L., Harmon, D., Kasif, S., White, O., and Salzberg, S.L. (1999) 21 
Improved microbial gene identification with GLIMMER. Nucleic Acids Res 27: 4636–22 
4641. 23 
- Demarre, G., Guérout, A.M., Matsumoto-Mashimo, C., Rowe-Magnus, D.A., 24 
Marlière, P., and Mazel, D. (2005) A new family of mobilizable suicide plasmids based 25 
on broad host range R388 plasmid (IncW) and RP4 plasmid (IncPalpha) conjugative 26 
machineries and their cognate Escherichia coli host strains. Res Microbiol 156: 245-27 
255. 28 
24 
 
- Devesse, L., Smirnova, I., Lönneborg, R., Kapp, U., Brzezinski, P., Leonard, G.A., 1 
and Dian, C. (2011) Crystal structures of DntR inducer binding domains in complex 2 
with salicylate offer insights into the activation of LysR-type transcriptional regulators. 3 
Mol Microbiol 81:354-367. 4 
- Duan, Y., Zhou, M., Guo, S., Ding, L., Gao, K., and Liu, X. (2012) Cloning and 5 
preliminary identification of SptR, a LuxR-like regulator from Serratia plymuthica. Afr J 6 
Microbiol Res 6: 6333–6339. 7 
- Ezezika, O.C., Haddad, S., Clark, T.J., Neidle, E.L., and Momany, C. (2007) 8 
Distinct effector-binding sites enable synergistic transcriptional activation by BenM, a 9 
LysR-type regulator. J Mol Biol 367:616-629. 10 
- Fischbach, M.A., and Walsh, C,T. (2009) Antibiotics for emerging pathogens. 11 
Science 325: 1089-93. 12 
- Frazer, K.A., Pachter, L., Poliakov, A., Rubin, E.M., and Dubchak, I. (2004) VISTA. 13 
Computational tools for comparative genomics. Nucleic Acids Res 32: W273–W279. 14 
- Fredenhagen, A., Tamure, S.Y., Kenny, P.T.M., Komura, H., Naya, Y., and 15 
Nakanishi, K. (1987) Andrimid, a new peptide antibiotic produced by an intracellular 16 
bacterial symbiont isolated from a brown planthopper. J Am Chem Soc 109: 4409–17 
4411. 18 
- Freiberg, C., Brunner, N.A., Schiffer, G., Lampe, T., Pohlmann, J., Brands, M., et 19 
al. (2004) Identification and characterization of the first class of potent bacterial acetyl-20 
CoA carboxylase inhibitors with antibacterial activity. J Biol Chem 279: 26066-26073. 21 
- Fortin, P.D., Walsh, C.T., and Magarvey, N.A. (2007) A transglutaminase 22 
homologue as a condensation catalyst in antibiotic assembly lines. Nature 448: 824-23 
827. 24 
- Graff, J.R., Forschner-Dancause, S.R., Menden-Deuer, S., Long, R.A., and 25 
Rowley, D.C. (2013) Vibrio cholerae exploits sub-lethal concentrations of a competitor-26 
produced antibiotic to avoid toxic interactions. Front Microbiol 4: 8. 27 
25 
 
- Gurney, R., and Thomas, C.M. (2011) Mupirocin: biosynthesis, special features 1 
and applications of an antibiotic from a gram-negative bacterium. Appl Microbiol 2 
Biotechnol 90: 11-21. 3 
- Haas, D., and Défago, G. (2005) Biological control of soil-borne pathogens by 4 
fluorescent pseudomonads. Nat Rev Microbiol 3: 307-319. 5 
- Harwood, J.L. (2007) Lipid metabolism. In The lipid handbook, 3rd edition. 6 
Harwood, J.L., Gunstone, F.D. and Dijkstra, A.J. (eds.). CRC Press, New York, pp. 7 
637–702. 8 
- Hellberg, J.E., Matilla, M.A., and Salmond, G.P. (2015) The broad-spectrum 9 
antibiotic, zeamine, kills the nematode worm Caenorhabditis elegans. Front Microbiol 10 
6:137. 11 
- Hérault, E., Reverchon, S., and Nasser, W. (2014) Role of the LysR-type 12 
transcriptional regulator PecT and DNA supercoiling in the thermoregulation of pel 13 
genes, the major virulence factors in Dickeya dadantii. Environ Microbiol 16: 734-45. 14 
- Herrero, M., de Lorenzo, V., and Timmis, K.N. (1990) Transposon vectors 15 
containing nonantibiotic resistance selection markers for cloning and stable 16 
chromosomal insertion of foreign genes in Gram-negative bacteria. J Bacteriol 172: 17 
6557-6567. 18 
- Hertweck, C. (2009) The biosynthetic logic of polyketide diversity. Angew Chem Int 19 
Ed Engl 48: 4688–4716. 20 
- Hökeberg, M., Gerhardson, B., and Johnsson, L. (1997) Biological control of cereal 21 
seed-borne diseases by seed bacterization with greenhouse-selected bacteria. Eur J 22 
Plant Pathol 103: 25-33. 23 
- Jeong, H., Kloepper, J.W., and Ryu, C.M. (2015) Genome sequence of 24 
rhizobacterium Serratia marcescens strain 90-166, which triggers induced systemic 25 
resistance and plant growth promotion. Genome Announc 3(3). pii: e00667-15. 26 
- Jin, M., Fischbach, M.A., and Clardy, J. (2006) A biosynthetic gene cluster for the 27 
acetyl-CoA  carboxylase inhibitor andrimid. J Am Chem Soc 128: 10660-10661. 28 
26 
 
- Kai, K., Ohnishi, H., Mori, Y., Kiba, A., Ohnishi, K., and Hikichi, Y. (2014) 1 
Involvement of ralfuranone production in the virulence of Ralstonia solanacearum OE1-2 
1. Chembiochem 15: 2590-2597. 3 
- Kaniga, K., Delor, I., and Cornelis, G.R. (1991) A wide-host range suicide vector 4 
for improving reverse genetics in Gram-negative bacteria: inactivation of the blaA gene 5 
of Yersinia enterocolitica. Gene 109: 137-141. 6 
- Klaponski, N., Selin, C., Duke, K., Spicer, V., Fernando, D.W., Belmonte, M.F., and 7 
de Kievit, T.R. (2014) The requirement for the LysR-type regulator PtrA for 8 
Pseudomonas chlororaphis PA23 biocontrol revealed through proteomic and 9 
phenotypic analysis. BMC Microbiol 14: 94. 10 
- Lewis, K. (2013) Platforms for antibiotic discovery. Nat Rev Drug Discov 12: 371-11 
387. 12 
- Li, S., Huang, X., Wang, G., and Xu, Y. (2012) Transcriptional activation of 13 
pyoluteorin operon  mediated by the LysR-type regulator PltR bound at a 22 bp lys box 14 
in Pseudomonas aeruginosa M18. PLoS One 7:e39538. 15 
- Liu, G., Chater, K.F., Chandra, G., Niu, G., and Tan, H. (2013) Molecular 16 
regulation of antibiotic biosynthesis in Streptomyces. Microbiol Mol Biol Rev 77: 112-17 
143. 18 
- Liu, X., Fortin, P.D., and Walsh, C.T. (2008) Andrimid producers encode an acetyl-19 
CoA carboxyltransferase subunit resistant to the action of the antibiotic. Proc Natl Acad 20 
Sci USA 105:13321-13326. 21 
- Liu, X., Jia, J., Popat, R., Ortori, C.A., Li, J., Diggle, S.P., Gao, K., and Cámara, M. 22 
(2011) Characterisation of two quorum sensing systems in the endophytic Serratia 23 
plymuthica strain G3: differential control of motility and biofilm formation according to 24 
life-style. BMC Microbiol 11:26. 25 
- Long, R.A., Rowley, D.C., Zamora, E., Liu, J., Bartlett, D.H., and Azam, F. (2005) 26 
Antagonistic interactions among marine bacteria impede the proliferation of Vibrio 27 
cholerae. Appl Environ Microbiol 71: 8531-6. 28 
27 
 
- Lu, Y., He, J., Zhu, H., Yu, Z., Wang, R., Chen, Y., et al. (2011) An orphan 1 
histidine kinase, OhkA, regulates both secondary metabolism and morphological 2 
differentiation in Streptomyces coelicolor. J Bacteriol 193: 3020-3032. 3 
- Lugtenberg, B., and Kamilova, F. (2009) Plant-growth-promoting rhizobacteria. 4 
Annu Rev Microbiol 63: 541-556. 5 
- Machado, H., Sonnenschein, E.C., Melchiorsen, J., and Gram, L. (2015) Genome 6 
mining reveals unlocked bioactive potential of marine Gram-negative bacteria. BMC 7 
Genomics 16: 158. 8 
- Maddocks, S.E., and Oyston, P.C. (2008) Structure and function of the LysR-type 9 
transcriptional regulator (LTTR) family proteins. Microbiology 154: 3609-23. 10 
- Magarvey, N.A., Fortin, P.D., Thomas, P.M., Kelleher, N.L., and Walsh, C.T. 11 
(2008) Gatekeeping versus promiscuity in the early stages of the andrimid biosynthetic 12 
assembly line. ACS Chem Biol 3: 542-54. 13 
- Mao, X.M., Sun, Z.H., Liang, B.R., Wang, Z.B., Feng, W.H., Huang, F.L., and Li, 14 
Y.Q. (2013) Positive feedback regulation of stgR expression for secondary metabolism 15 
in Streptomyces coelicolor. J Bacteriol 195:2072-2078. 16 
- Matilla, M.A., Leeper, F.J., and Salmond, G.P. (2015) Biosynthesis of the 17 
antifungal haterumalide, oocydin A, in Serratia, and its regulation by quorum sensing, 18 
RpoS  and Hfq. Environ Microbiol 17: 2993-3008. 19 
- Matilla, M.A., and Salmond, G.P.C. (2014) The Viunalikevirus, bacteriophage 20 
φMAM1, is a broad host range, high efficiency generalised transducing phage that 21 
infects environmental and clinical isolates of the enterobacteria, Serratia and Kluyvera. 22 
Appl Environ Microbiol 80: 6446–6457. 23 
- Matilla, M.A., Stöckmann, H., Leeper, F.J., and Salmond, G.P.C. (2012) Bacterial 24 
biosynthetic gene clusters encoding the anti-cancer haterumalide class of molecules: 25 
biogenesis of the broad spectrum antifungal and antioomycete compound, oocydin A. J 26 
Biol Chem 287: 39125-39138. 27 
28 
 
- Mendes, R., Garbeva, P., and Raaijmakers, J.M. (2013) The rhizosphere 1 
microbiome: significance of plant beneficial, plant pathogenic, and human pathogenic 2 
microorganisms. FEMS Microbiol Rev 37: 634-663. 3 
- Monferrer, D., Tralau, T., Kertesz, M.A., Dix, I., Solà, M., and Usón, I. (2010) 4 
Structural studies on the full-length LysR-type regulator TsaR from Comamonas 5 
testosteroni T-2 reveal a novel open conformation of the tetrameric LTTR fold. Mol 6 
Microbiol 75:1199-1214. 7 
- Mousa, W.K., and Raizada, M.N. (2015) Biodiversity of genes encoding anti-8 
microbial traits within plant associated microbes. Front Plant Sci 6: 231.  9 
- Müller, H., Westendorf, C., Leitner, E., Chernin, L., Riedel, K., Schmidt, S., Eberl, 10 
L., and Berg, G. (2009) Quorum-sensing effects in the antagonistic rhizosphere 11 
bacterium Serratia plymuthica HRO-C48. FEMS Microbiol Ecol 67: 468-78. 12 
- Needham, J., Kelly, M.Y., Ishige, M., and Andersen, R.J. (1994) Andrimid and 13 
moiramides A-C, metabolites produced in culture by a marine isolate of the bacterium 14 
Pseudomonas Fluorescens - structure elucidation and biosynthesis. J Org Chem 59: 15 
2058–2063. 16 
- Nett, M., Ikeda, H., and Moore, B.S. (2009) Genomic basis for natural product 17 
biosynthetic diversity in the actinomycetes. Nat Prod Rep 26: 1362-1384. 18 
- Newman, D.J., and Cragg, G.M. (2007) Natural products as sources of new drugs 19 
over the last 25 years. J Nat Prod 70: 461-477. 20 
- Oclarit, J.M., Okada, H., Ohta, S., Kaminura, K., Yamaoka, Y., Iizuka, T., 21 
Miyashiro, S., and Ikegami, S. (1994) Anti-Bacillus substance in the marine sponge, 22 
Hyatella species, produced by an associated Vibrio species bacterium. Microbios 78: 7-23 
16. 24 
- Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-25 
time RT-PCR. Nucleic Acids Res 29: e45. 26 
- Pidot, S.J., Coyne, S., Kloss, F., and Hertweck, C. (2014) Antibiotics from 27 
neglected bacterial sources. Int J Med Microbiol 304: 14-22. 28 
29 
 
- Pritchard, L., Humphris, S., Baeyen, S., Maes, M., Van Vaerenbergh, J., 1 
Elphinstone, J., Saddler, G., and Toth, I. (2013a). Draft genome sequences of four 2 
Dickeya dianthicola and four Dickeya solani strains. Genome Announc 1(4). pii: 3 
e00087-12. 4 
- Raaijmakers, J.M., Paulitz, T.C., Steinberg, C., Alabouvette, C., and Moënne-5 
Loccoz, Y. (2009) The rhizosphere. A playground for soil-borne pathogen and 6 
beneficial microorganisms. Plant Soil 321: 341–361. 7 
- Ramsay, J. (2013) High-throughput β-galactosidase and β-glucuronidase assays 8 
using fluorogenic substrates. Bioprotocol 3: e827. 9 
- Ratnayake, N.D., Wanninayake, U., Geiger, J.H., and Walker, K.D. (2011) 10 
Stereochemistry and mechanism of a microbial phenylalanine aminomutase. J Am 11 
Chem Soc 133: 8531-8533. 12 
- Romeo, T., Vakulskas, C.A., and Babitzke, P. (2013) Post-transcriptional 13 
regulation on a global scale: form and function of Csr/Rsm systems. Environ Microbiol 14 
15: 313-24. 15 
- Sambrook, J., Fritsch, E.F., and Maniatis, T. (1989) Molecular Cloning: A 16 
Laboratory Manual, 2nd edn. New York, NY, USA: Cold Spring Harbor Laboratory, 17 
Cold Spring Harbor Laboratory Press. 18 
- Sánchez, S., Chávez, A., Forero, A., García-Huante, Y., Romero, A., Sánchez, M., 19 
et al. (2010) Carbon source regulation of antibiotic production. J Antibiot 63:442-459. 20 
- Sánchez, L.A., Sierra, M.G., Siñeriz, F., and Delgado, O. (2013) Andrimid 21 
production at low temperature by a psychrotolerant Serratia proteamaculans strain. 22 
World J Microbiol Biotechnol 29: 1773-1781. 23 
- Sattely, E.S., Fischbach, M.A., and Walsh, C.T. (2008) Total biosynthesis: in vitro 24 
reconstitution of polyketide and nonribosomal peptide pathways. Nat Prod Rep 25: 25 
757-793.  26 
30 
 
- Singh, M.P., Mroczenski-Wildey, M.J., Steinberg, D.A., Andersen, R.J., Maiese, 1 
W.M., and Greenstein, M. (1997) Biological activity and mechanistic studies of 2 
andrimid. J Antibiot 50: 270-3. 3 
- Sola-Landa, A., Moura, R.S., and Martín, J.F. (2003) The two-component PhoR-4 
PhoP system controls both primary metabolism and secondary metabolite biosynthesis 5 
in Streptomyces lividans. Proc Natl Acad Sci USA 100: 6133-8. 6 
- Strobel, G., Li, J.Y., Sugawara, F., Koshino, H., Harper, J., and Hess, W.M. (1999) 7 
Oocydin A, a chlorinated macrocyclic lactone with potent anti-oomycete activity from 8 
Serratia marcescens. Microbiology 145: 3557-3564. 9 
- Suzuki, K, Okazaki, K, Tawaraya, K., Osaki, M., and Shinana, T. (2009) Gas 10 
chromatography–mass spectrometry associated global analysis of rice root exudates 11 
under aseptical conditions. Soil Sci Plant Nutr 55: 505-513. 12 
- Thaning, C., Welch, C.J., Borowicz, J.J., Hedman, R., and Gerhardson, B. (2001) 13 
Suppression of Sclerotinia sclerotiorum apothecial formation by the soil bacterium 14 
Serratia plymuthica: identification of a chlorinated macrolide as one of the causal 15 
agents. Soil Biol Biochem 33: 1817–1826. 16 
- Udwary, D.W., Zeigler, L., Asolkar, R.N., Singan, V., Lapidus, A., Fenical, W., 17 
Jensen, P.R., and Moore, B.S. (2007) Genome sequencing reveals complex secondary 18 
metabolome in the marine actinomycete Salinispora tropica. Proc Natl Acad Sci USA 19 
104:10376-10381. 20 
- Uren, N.C. (2007) Types, amounts, and possible functions of compounds released 21 
into rhizosphere by soil-grown plants. In The Rhizosphere: Biochemistry and organic 22 
substances at the soil-plant interface. Pinton, R., Varanini, Z. and Nannipieri, P. (eds.) 23 
CRC Press, New York, pp. 1-21.  24 
- Vogel, J., and Luisi, B.F. (2011) Hfq and its constellation of RNA. Nat Rev 25 
Microbiol 9: 578–589. 26 
31 
 
- Wang, H., Fewer, D.P., Holm, L., Rouhiainen, L., and Sivonen, K. (2014) Atlas of 1 
nonribosomal peptide and polyketide biosynthetic pathways reveals common 2 
occurrence of nonmodular enzymes. Proc Natl Acad Sci USA 111: 9259–9264 3 
- Wietz, M., Mansson, M., Gotfredsen, C.H., Larsen, T.O., and Gram, L. (2010) 4 
Antibacterial compounds from marine Vibrionaceae isolated on a global expedition. 5 
Mar Drugs 8: 2946-60. 6 
- Wietz, M., Månsson, M., and Gram, L. (2011) Chitin stimulates production of the 7 
antibiotic andrimid in a Vibrio coralliilyticus strain. Environ Microbiol Rep 3: 559-64. 8 
- Wilf, N.M., and Salmond, G.P.C. (2012) The stationary phase sigma factor, RpoS, 9 
regulates the production of a carbapenem antibiotic, a bioactive prodigiosin and 10 
virulence in the enterobacterial pathogen Serratia sp. ATCC 39006. Microbiology 158: 11 
648–658. 12 
- Wilf, N.M., Williamson, N.R., Ramsay, J.P., Poulter, S., Bandyra, K.J., and 13 
Salmond, G.P.C. (2011) The RNA chaperone, Hfq, controls two luxR-type regulators 14 
and plays a key role in pathogenesis and production of antibiotics in Serratia sp. ATCC 15 
39006. Environ Microbiol 13: 2649-2666. 16 
- Williamson, N.R., Fineran, P.C., Leeper, F.J., and Salmond, G.P.C. (2006) The 17 
biosynthesis and regulation of bacterial prodiginines. Nat Rev Microbiol 4: 887–899. 18 
- Woodcock, D.M., Crowther, P.J., Doherty, J., Jefferson, S., DeCruz, E., Noyer- 19 
Weidner, M., et al. (1989) Quantitative evaluation of Escherichia coli host strains for 20 
tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids 21 
Res 17: 3469-3478. 22 
- Woodford, N., Turton, J.F., and Livermore, D.M. (2011) Multiresistant Gram-23 
negative bacteria: the role of high-risk clones in the dissemination of antibiotic 24 
resistance. FEMS Microbiol Rev 35: 736-755. 25 
- Zhao, C., Coughlin, J.M., Ju, J., Zhu, D., Wendt-Pienkowski, E., Zhou, X., et al. 26 
(2010) Oxazolomycin biosynthesis in Streptomyces albus JA3453 featuring an 27 
32 
 
"acyltransferase-less" type I polyketide synthase that incorporates two distinct extender 1 
units. J Biol Chem 285: 20097-108.  2 
- Zhou, M., Gao, K., Zeng, J., Yu, X., Wu, Y., Ge, J., et al. (2012) Role of the RNA-3 
binding protein Hfq in Serratia plymuthica. Front Biosci 4: 1263–1275. 4 
 5 
 6 
 7 
 8 
 9 
 10 
 11 
 12 
 13 
 14 
 15 
 16 
 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
33 
 
Table 1. Bacteria and phages used in this study 1 
Bacteria/phage Genotype or relevant characteristica Reference or source 
Escherichia coli DH5 supE44 lacU169(Ø80lacZΔ M15) hsdR17 (rK
−mK−) recA1 endA1 
gyrA96 thi-1 relA1 Woodcock et al., (1989) 
E. coli CC118pir araD, Δ(ara, leu), ΔlacZ74, phoA20, galK, thi-1, rspE, rpoB, argE, recA1, λpir Herrero et al., (1990) 
E. coli HH26  Mobilizing strain for conjugal transfer Kaniga et al., (1991) 
E. coli β2163 F- RP4-2-Tc::Mu ΔdapA::(erm-pir); KmR EmR Demarre et al., (2005) 
Serratia plymuthica A153 Wild type, rhizosphere isolate Hökeberg et al., (1997) 
LacZ A153 ΔlacZ (1470 bp Δ)  Matilla et al., (2015) 
VN1  A153 transposon mutant admH::Tn-KRCPN1lacZ; KmR This study 
VN2  A153 transposon mutant admK::Tn-KRCPN1lacZ; KmR This study 
VN3  A153 transposon mutant admO::Tn-KRCPN1lacZ; KmR This study 
VN7  A153 transposon mutant admM::Tn-KRCPN1; KmR This study 
VN9  A153 transposon mutant admJ::Tn-KRCPN1; KmR This study 
VN11  A153 transposon mutant admC::Tn-KRCPN1lacZ; KmR This study 
VN12  A153 transposon mutant admP::Tn-KRCPN1; KmR This study 
VN17  A153 transposon mutant admO::Tn-KRCPN1; KmR This study 
VN21  A153 transposon mutant admK::Tn-KRCPN1; KmR This study 
VN22  A153 transposon mutant admP::Tn-KRCPN1lacZ; KmR This study 
VN23  A153 transposon mutant admF::Tn-KRCPN1; KmR This study 
VN24  A153 transposon mutant admE::Tn-KRCPN1lacZ; KmR This study 
VN26  A153 transposon mutant admS::Tn-KRCPN1lacZ; KmR This study 
A153JH6  A153 ΔlacZ, zmn13::Tn-KRCPN1; Zeamine-; KmR Hellberg et al., (2015) 
ANDV  A153 ΔadmV (336 bp Δ) This study 
ANDW  A153 ΔadmW (150 bp Δ) This study 
ANDX  A153 ΔadmX (789 bp Δ) This study 
XJH6  A153 ΔadmX, zmn13::Tn-KRCPN1; andrimid-, zeamine-; KmR This study 
ARpoS  A153 rpoS::Km; KmR Matilla et al., (2015) 
AHfq  A153 Δhfq::Km (252 bp Δ); KmR Matilla et al., (2015) 
A153H  A153 Δhfq (252 bp Δ) This study 
A153HL  A153 ΔlacZ, Δhfq This study 
LVN2  A153 ΔlacZ, admK::Tn-KRCPN1lacZ; generated by transduction using ϕMAM1; KmR This study 
HLVN2  A153 ΔlacZ, Δhfq, admK::Tn-KRCPN1lacZ; generated by transduction using ϕMAM1; KmR This study 
XLVN2  A153 ΔlacZ, ΔadmX, admK::Tn-KRCPN1lacZ; generated by transduction using ϕMAM1; KmR This study 
ASptI  A153 in-frame sptI (483 bp Δ) Matilla and Salmond, unpublished 
ASptR  A153 sptR::Km; KmR Matilla and Salmond, unpublished 
ASplR  A153 splR::Km; KmR Matilla and Salmond, unpublished 
ASpsR  A153 spsR::Km; KmR Matilla and Salmond, unpublished 
A153C  A153 in-frame csrB (267 bp Δ) Matilla and Salmond, unpublished 
Serratia marcescens MSU97 Wild type, plant epiphyte, pigmented Strobel et al., (1999) 
Bacillus subtilis JH642 pheA1 trpC2 J.A. Hoch 
Dickeya solani MK10 Wild type, plant pathogen Pritchard et al., (2013) 
Xanthomonas campestris pv. 
campestris  Wild type, plant pathogen R. Penyalver 
Phages 
ϕMAM1 Generalized transducing phage for S. plymuthica A153 Matilla and Salmond (2014) 
aThe following abbreviations are used: Km, kanamycin; Tc, tetracycline; Em, erythromycin. 2 
	3 
	4 
	5 
	6 
	7 
	8 
	9 
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FIGURE AND FIGURE LEGENDS 1 
 2 
Fig. 1. Identification and characterization of the andrimid gene cluster in Serratia 3 
plymuthica A153. A, Antibacterial activities against Bacillus subtilis of Serratia 4 
plymuthica A153, and derivative strains with mutations in the zeamine (zmn) and 5 
andrimid (adm) biosynthetic gene clusters. B, Genetic organization of the adm gene 6 
cluster in S. plymuthica A153. The same genetic organization was found in S. 7 
marcescens MSU97 and S. marcescens 90-166 (Fig. S3). Location of the Tn-KRCPN1 8 
transposon insertions and in-frame deletion mutants are indicated by black and red 9 
arrows, respectively. Colour code representing the functional category of each gene of 10 
the gene cluster is given where possible, based on the biosynthetic pathway for 11 
andrimid proposed by Jin et al., (2006). Genes admV, admW and admX were not 12 
previously associated with the regulation or biosynthesis of andrimid.  13 
35 
 
 1 
Fig. 2. Role of the hypothetical protein AdmV in the biosynthesis of andrimid. 2 
Bioactivities against Bacillus subtilis of an in-frame admV deletion mutant of Serratia 3 
plymuthica A153. Induction of the expression of the wild type proteins was done by 4 
addition of 1 mM of IPTG. The bioassays were repeated at least three times, and 5 
representative results are shown. Pictures were taken after 48 h of incubation at 25 °C. 6 
 7 
 8 
 9 
 10 
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1 
  2 
Figure 3: The andrimid gene cluster is organized as a polycistronic 3 
transcriptional unit. A, Schematic representation of the adm gene cluster in Serratia 4 
plymuthica A153. Lines labelled 1-21 above the gene cluster represent the regions 5 
amplified by RT-PCR and shown in B. Numbers below the arrows represent the 6 
intergenic distance in base pairs, and negative numbers indicate overlapping genes. B, 7 
Transcript analysis by RT-PCR using primers designed to span the intergenic region 8 
between two adjacent genes. For each region, three PCR analyses were carried out: +, 9 
RT-PCR on cDNA; -, negative control with no reverse transcriptase; c, positive control 10 
with genomic DNA as template. Culture samples for RNA isolation were taken at early 11 
stationary phase (Fig. 4).    12 
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 1 
Fig. 4. AdmX and Hfq regulate andrimid production by activating the expression 2 
of the adm biosynthetic gene cluster. A, β-galactosidase activity (filled symbols) 3 
throughout growth measured from a chromosomal fusion admK::lacZ in Serratia 4 
plymuthica A153 LacZ (circles), and its ∆admX (squares) and ∆hfq (triangles) 5 
derivative strains in LB medium at 25 °C. Open symbols represent bacterial growth. 6 
Data are the mean and standard deviation of three biological replicates. Arrow, time 7 
point when samples for RT-PCR and qPCR were taken (Fig. 3 and S6). B, Andrimid 8 
production by S. plymuthica A153 strain JH6 (zeamine negative) throughout growth in 9 
LB medium at 25 °C. For the assays, a Bacillus subtilis top agar lawn was prepared 10 
and 300 µl of filter-sterilized supernatants were added to holes punched in the Bacillus 11 
bioassay plates.  12 
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 1 
Fig. 5. The production of andrimid in Serratia plymuthica A153 is temperature-2 
dependent and correlates with the expression of the adm gene cluster. A, Halos 3 
of antibiosis against Bacillus subtilis of filter-sterilized supernatants of A153 strain JH6 4 
(zeamine negative) grown in LB at different temperatures. The bioassays were 5 
repeated at least three times, and representative results are shown. B, β-6 
Galactosidase activity (filled symbols) throughout growth measured from the 7 
chromosomal fusion admK::lacZ in Serratia plymuthica A153 LacZ. Open symbols 8 
represent bacterial growth. Data are the mean and standard deviation of three 9 
biological replicates. Doubling times at 20, 25, 30 and 35 ºC were 66.8 ± 0.4, 47.3 ± 10 
0.7, 40.7 ± 0.4 and 40.5 ± 0.2 minutes, respectively.  11 
 12 
 13 
 14 
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 1 
Fig. 6. Effect of carbon source on the production of andrimid and expression of 2 
the adm gene cluster in Serratia plymuthica A153.  A, Halos of antibiosis against 3 
Bacillus subtilis of filter-sterilized supernatants of A153 strain JH6 (zeamine negative) 4 
grown in minimal medium with different carbon sources. The bioassays were repeated 5 
at least three times, and representative results are shown. All the carbon sources were 6 
used at a final concentration of 15 mM. With the exception of lactose, all carbon 7 
sources used are frequently found in plant root exudates. Bars, 5 mm. B, β-8 
galactosidase activity (filled symbols) throughout growth measured from the 9 
chromosomal fusion admK::lacZ in Serratia plymuthica A153 LacZ in minimal medium 10 
with different carbon sources. Open symbols represent bacterial growth. Data are the 11 
mean and standard deviation of three biological replicates. Growth and doubling times 12 
of A153 in all the carbon sources used are shown in Fig. S5.   13 
40 
 
  1 
Fig. 7. The LysR-type regulator AdmX, and the RNA chaperone Hfq positively 2 
regulate the biosynthesis of andrimid. Bioactivities against Bacillus subtillis of S. 3 
plymuthica A153 and derivative strains are shown (A, B). In frame deletion of admX 4 
was functionally complemented by the in trans expression of AdmX using the pQE80L-5 
based vector, pMAMV185 (A). Induction of the expression of the AdmX was done by 6 
addition of 0.1 mM of IPTG. Complementation of the ∆hfq strain was done using a 7 
pQE-80L-based vector (Fig. S8). The bioassays were repeated at least three times, 8 
and representative results are shown. Pictures were taken after 48 h of incubation at 9 
25°C.  10 
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Supplementary Table S1: Identity at DNA level of the andrimid gene clusters between producing strains. 
Strain  DNA Homology (%) 
 Eh335 MSU97 A153 SWAT-3 90-166 S2052 
Pantoea agglomerans Eh335 X 83.2 84.2 70.1 81.7 70.1 
Serratia marcescens MSU97 83.2 X 86.4 71.8 89.1 71.2 
Serratia plymuthica A153 84.2 86.4 X 71.4 84.8 71.4 
Vibrio SWAT-3 70.1 71.8 71.4 X 70.7 99.0 
Serratia marcescens 90-166 81.7 89.1 84.8 70.7 X 70.7 
Vibrio coralliilyticus S2052 70.1 71.2 71.4 99.0 70.7 X 
3 
 
Supplementary Table S2. Additional bacterial strains used in this study. 
Bacteria Genotype or relevant characteristica Reference or source 
Agrobacterium tumefaciens C58  Wild type; Plant pathogen Wood et al., 2001 
Bacillus thuringiensis subsp. 
kurstaki strain HD73 Wild type; Toxic to lepidopteran larvae Liu et al., (2013) 
Dickeya solani MK10 Wild type, plant pathogen Pritchard et al., (2013) 
Dickeya solani MK16 Wild type, plant pathogen Pritchard et al., (2013) 
Dickeya solani IPO 2222 Wild type, plant pathogen Pritchard et al., (2013) 
Escherichia coli EPI100-T1R  
 
F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZΔM15 ΔlacX74 
recA1 endA1 araD139 Δ(ara, leu)7697 galU galK λ- rpsL (StrR) 
nupG trfA tonA 
Epicentre 
Escherichia coli OP50 Uracil auxotroph Brenner (1974) 
Kluyvera cryorescens 2Kr27  
 Wild type; Rhizosphere isolate Berg et al., (2002) 
Pantoea agglomerans 10Bp14  
 Wild type; Rhizosphere isolate Berg et al., (2002) 
Pantoea agglomerans 9Rz4  Wild type; Rhizosphere isolate Berg et al., (2002) 
Serratia marcescens 12  Serratia marcescens strain 3888; wild type, clinical isolate Aucken and Pitt (1998) 
Serratia proteomaculans 3Rc15  
 Wild type; Rhizosphere isolate Berg et al., (2002) 
Serratia proteomaculans 9Bp4  
 Wild type; Rhizosphere isolate Berg et al., (2002) 
Serratia plymuthica 4Rx5  
 Wild type; Rhizosphere isolate Berg et al., (2002) 
Weeksella zoohelcum 5Rr4  
 Wild type; Rhizosphere isolate Berg et al., (2002) 
Weeksella zoohelcum 8Rx9  
 Wild type; Rhizosphere isolate Berg et al., (2002) 
Xenorhabdus luminescens 3Rp5  
 Wild type; Rhizosphere isolate Berg et al., (2002) 
Xanthomonas campestris  
pv. campestris  
  Wild type; Plant pathogen R. Penyalver 
Yersinia enterocolitica  
 Wild type Lab stock 
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Supplementary Table S3. Oligonucleotides used in this study. 
Number Name Sequence (5´- 3') Description Source 
1 PF106 GACCACACGTCGACTAGTGCNNNNNNNNNNAGAG Random primed PCR primer 1 Fineran et al., (2005) 
2 PF107 GACCACACGTCGACTAGTGCNNNNNNNNNNACGCC Random primed PCR primer 2 Fineran et al., (2005) 
3 PF108 GACCACACGTCGACTAGTGCNNNNNNNNNNGATAC Random primed PCR primer 3 Fineran et al., (2005) 
4 PF109 GACCACACGTCGACTAGTGC Random primed PCR adapter primer Fineran et al., (2005) 
5 MAMV1-KRCPN1 GGAATTGATCCGGTGGATG TnKRCPN1 specific primer Matilla et al., (2012) 
6 MAMV2-KRCPN1 GCATAAAGCTTGCTCAATCAATCAC TnKRCPN1 specific primer Matilla et al., (2012) 
7 admVA-F AATTCATGTCCCCACTCGC  RT‐PCR mapping forward primer product 1 This study 
8 admVA-R AATTCATGTCCCCACTCGC  RT‐PCR mapping reverse primer product 1 This study 
9 admAB-F AATACAGCATTGACCTGGGG  RT‐PCR mapping forward primer product 2 This study 
10 admAB-R TTATCGTATGTCCGGCCATC  RT‐PCR mapping reverse primer product 2 This study 
11 admBC-F GGATCTCAATAGGCAGGGC  RT‐PCR mapping forward primer product 3 This study 
12 admBC-R CGGCATTGTTCACCAGAAC  RT‐PCR mapping reverse primer product 3 This study 
13 admCD-F CCGGGCTACATCGATACTGA  RT‐PCR mapping forward primer product 4 This study 
14 admCD-R CGTGGCTCTTAAGGCAAAAA  RT‐PCR mapping reverse primer product 4 This study 
15 admDE-F CGATGGGCATTAAAAGCAAC  RT‐PCR mapping forward primer product 5 This study 
16 admDE-R CAGCAGTACACCCGGAACA  RT‐PCR mapping reverse primer product 5 This study 
17 admEF-F GTCGAATATTGCCGGGATT  RT‐PCR mapping forward primer product 6 This study 
18 admEF-R TCTTAAATCAAGCCCGCGT  RT‐PCR mapping reverse primer product 6 This study 
19 admFG-F GGTGCGGTGATTTAGACCTC  RT‐PCR mapping forward primer product 7 This study 
20 admFG-R TGAATTCCTGCTGCCTGAG  RT‐PCR mapping reverse primer product 7 This study 
21 admGH-F AAGCGTTTACCAGCACCAAC  RT‐PCR mapping forward primer product 8 This study 
22 admGH-R CTCGTCATTTCGGCTTGAG  RT‐PCR mapping reverse primer product 8 This study 
23 admHI-F GGACATTGTCTCTTTTGGGC  RT‐PCR mapping forward primer product 9 This study 
24 admHI-R TCCACCGAATCGAGGATATC  RT‐PCR mapping reverse primer product 9 This study 
25 admIJ-F GATTACGGCCTGTCATTTGG  RT‐PCR mapping forward primer product 10 This study 
26 admIJ-R CTGACATGATCATCGCCAA  RT‐PCR mapping reverse primer product 10 This study 
27 admJK-F TGATCCCAAATATCTTCGCC  RT‐PCR mapping forward primer product 11 This study 
5 
 
28 admJK-R CCTGATAAGAATACGCGGCA  RT‐PCR mapping reverse primer product 11 This study 
29 admKL-F CGATTCTTCTGGACTGTCGG  RT‐PCR mapping forward primer product 12 This study 
30 admKL-R TGTTAACGACTGGGCAGTTG  RT‐PCR mapping reverse primer product 12 This study 
31 admLM-F GTCAGCCCCGTGATATTGAA  RT‐PCR mapping forward primer product 13 This study 
32 admLM-R CAAACTGATCGACTCCCTCC  RT‐PCR mapping reverse primer product 13 This study 
33 admMN-F GATAATCCCCGGCTCAATCT  RT‐PCR mapping forward primer product 14 This study 
34 admMN-R TCGCATTGTCACCATCATTC  RT‐PCR mapping reverse primer product 14 This study 
35 admNO-F TCGAAACAAGACAGAGACGC  RT‐PCR mapping forward primer product 15 This study 
36 admNO-R GGTAGGTATGATTGCTGCCC  RT‐PCR mapping reverse primer product 15 This study 
37 admOP-F TCTCTGGTAGGGAGAAACGG  RT‐PCR mapping forward primer product 16 This study 
38 admOP-R ATAATACAACGCCCTCGACG  RT‐PCR mapping reverse primer product 16 This study 
39 admPQ-F CTGTGGGTAAGATCTTGGGC  RT‐PCR mapping forward primer product 17 This study 
40 admPQ-R GCGGCAGCTAAGGTGTAACT  RT‐PCR mapping reverse primer product 17 This study 
41 admQR-F TGTTTAGTGGTTTGGCTGCC  RT‐PCR mapping forward primer product 18 This study 
42 admQR-R ATTCCACACCAAAATCCGAG  RT‐PCR mapping reverse primer product 18 This study 
43 admRS-F GGATATGTGACAAATCGGCA  RT‐PCR mapping forward primer product 19 This study 
44 admRS-R CGTCATGCTTTGTTGGTTTG  RT‐PCR mapping reverse primer product 19 This study 
45 admSW-F TGAGATTGCGGATGAAATGA  RT‐PCR mapping forward primer product 20 This study 
46 admSW-R ATACGAACAGATAGCCCGCA  RT‐PCR mapping reverse primer product 20 This study 
47 admWT-F GCTGATTGTCGCGATTATTG  RT‐PCR mapping forward primer product 21 This study 
48 admWT-R ATGTGGTGATCGCACTTCG  RT‐PCR mapping reverse primer product 21  This study 
49 admV-KpnI-F TAATGGTACCTAGTATCGTGGGTTGTAGTCC Forward primer to clone upstream flanking region of admV for in-frame deletion This study 
50 admV-BamHI-R TAATGGATCCCGTAGAACCATACTATAGCACTCC Reverse primer to clone upstream flanking region of admV for in-frame deletion This study 
51 admV-BamHI-F TAATGGATCCTAACTGGACCCAGTTCGTG Forward primer to clone downstream flanking region of admV for in-frame 
deletion
This study 
52 admV-HindIII-R TAATAAGCTTTCATGTTATCCAGCGCTATC Reverse primer to clone downstream flanking region of admV for in-frame 
deletion 
This study 
53 admW-EcoRI-F TAATGAATTCATGGCACTCGACATGATGAG Forward primer to clone upstream flanking region of admW for in-frame deletion This study 
54 admW-BamHI-R TAATGGATCCTTATAGACGGCAAAGTGGCG Reverse primer to clone upstream flanking region of admW for in-frame deletion This study 
55 admW-BamHI-F TAATGGATCCGCCACGAGCGTAGTAAAGC Forward primer to clone downstream flanking region of admW for in-frame 
deletion 
This study 
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56 admW-HindIII-R TAATAAGCTTGTCAGCACAGAGATGTACGG Reverse primer to clone downstream flanking region of admW for in-frame 
deletion 
This study 
57 admX-EcoRI-F TAATGAATTCGGTCGTATCGGCTGACA Forward primer to clone upstream flanking region of admX for in-frame deletion This study 
58 admX-BamHI-R TAATGGATCCGCCGCATGTCATCACGGTG Reverse primer to clone upstream flanking region of admX for in-frame deletion This study 
59 admX-BamHI-F TAATGGATCCCGGCTACGTAACGAGCTCAG Forward primer to clone downstream flanking region of admX for in-frame 
deletion 
This study 
60 admX-HindIII-R TAATAAGCTTCCTGGCGGAATTCATGG Reverse primer to clone downstream flanking region of admX for in-frame 
deletion 
This study 
61 AdmX-RBS-EcoRI-
F
TAATGAATTCACCTAGGATGAACAGTCTATGAAAC Forward primer to clone admX into pTRB30. This study 
62 AdmX-EcoRI-R TAATGAATTCCGCTTATATGAAAGCATTTAGACTGG Reverse primer to clone admX into pTRB30 This study 
63 AdmV-BamHI-F TAATGGATCCGGCACCGTCAGGTGCCCTTTTG Forward primer to clone admV into pTRB30. This study 
64 AdmV-KpnI-R TAATGGTACCTCGATCGCAAAACGGCTGAAATGAG Reverse primer to clone admV into pTRB30 This study 
65 AdmX-qPCR-F GGGTGCCGTCGAGATTGATAG Forward primer for qRT-PCR This study 
66 AdmX-qPCR-R ATGTCGGTGATGCAGCATCC Reverse primer for qRT-PCR This study 
67 AdmV-qPCR-F TTGGCTCCGAAGGCAACAAG Forward primer for qRT-PCR This study 
68 AdmV-qPCR-R ACATCACGCAGATCCGTACC Reverse primer for qRT-PCR This study 
69 16SA153-qPCR-F ACTGAGACACGGTCCAGACT Forward primer for qRT-PCR This study 
70 16SA153-qPCR-R TTAGCCGGTGCTTCTTCTGC Reverse primer for qRT-PCR This study 
71 PadmX-KpnI-F TAATGGTACCATGCCACCTACATACTGC Forward primer to clone promoter region of admX into pMP220 This study 
72 PadmX-PstI-R TAATCTGCAGCATAGACTGTTCATCCTAGGTTATG Reverse primer to clone promoter region of admX into pMP220 This study 
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Supplementary Table S4. Plasmids used in this study. 
Plasmid Relevant characteristica Source 
pKNG101          SmR; oriR6K mob sacBR Kaniga et al., (1991) 
pUC18Not Ap
R; identical to pUC18 but with two NotI sites flanking pUC18 
polylinker Herrero et al., (1990) 
pNJ5000 TcR; Mobilizing plasmid used in marker exchange Grinter (1983) 
pKCPRN1 Km
R, TcR; Derivative of pDS1028uidA with the uidA and cat genes 
replaced with lacZ and km genes K. Roberts PhD 
pTRB30 Km
R; pQE-80L (Qiagen) based expression vector, ApR resistance cassette 
replaced by KmR. IPTG-inducible promoter, ColE1 origin. T. Blower 
pMP220 TcR; oriRK2 ′lacZ Spaink et al., (1987) 
pMAMV117 Ap
R; 1.4-kb PCR product containing a 252 bp deletion of hfq of A153 
inserted into the EcoRI/SphI sites of pUC18Not Matilla et al., (2015) 
pMAMV193 Sm
R; 1.5-kb NotI fragment of pMAMV117 was cloned at the same site in 
pKNG101 This study 
pMAMV144 Ap
R; 1.4-kb PCR product containing a 789 bp in frame deletion of admX 
of A153 inserted into the EcoRI/HindIII sites of pUC18Not This study 
pMAMV175 Sm
R; 1.5-kb NotI fragment of pMAMV144 was cloned at the same site in 
pKNG101 This study 
pMAMV189 Ap
R; 1.5-kb PCR product containing a 336 bp in frame deletion of admV 
of A153 inserted into the KpnI/HindIII sites of pUC18Not This study 
pMAMV191 Sm
R; 1.6-kb NotI fragment of pMAMV189 was cloned at the same site in 
pKNG101 This study 
pMAMV190 Ap
R; 1.5-kb PCR product containing a 150 bp in frame deletion of admW 
of A153 inserted into the EcoRI/HindIII sites of pUC18Not This study 
pMAMV192 Sm
R; 1.6-kb NotI fragment of pMAMV190 was cloned at the same site in 
pKNG101 This study 
pMAMV185 KmR; admX gene was cloned into the EcoRI site of pTRB30 This study 
pMAMV220 KmR; admV gene was cloned into the EcoRI site of pTRB30 This study 
pJEEUH13 KmR; hfq gene cloned into the expression vector pTRB30 Hellberg et al., (2015) 
pMAMV244 Tc
R; admX promoter region was cloned into the KpnI/PstI sites of 
pMP220 This study 
aAp, ampicillin; Km, kanamycin; Sm, streptomycin; Tc, tetracycline. 
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Supplementary Fig. S1: Structures of andrimid and moiramide B. The structure of 
andrimid consists of an unsaturated fatty acid chain, a pyrrolidinedione ring, a valine 
and glycine derived β-ketoamide and the amino acid β-phenylalanine. Chemical 
synthesis studies showed that the fatty acid chain and β-phenylalanine are involved in 
bacterial cell penetration of the antibiotic, whereas the pyrrolidinedione head and the β-
ketoamide moiety are responsible for the antibacterial activity (Pohlmann et al., 2005; 
Freiberg et al., 2006). 
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Supplementary Fig. S2. Antibacterial activity of Serratia marcescens MSU97 
against Bacillus subtilis.  
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Supplementary Fig. S3. Schematic representation of the andrimid gene clusters 
of Serratia marcescens MSU97, Serratia marcescens 90-166, Pantoea 
agglomerans Eh335, Vibrio coralliilyticus S2052 and Vibrionales bacterium 
SWAT-3. Numbers below the arrows represent the intergenic distance between 
contiguous genes, with negative numbers indicate overlapping genes.  
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Fig. S4. DNA homology between the andrimid gene cluster of Serratia plymuthica 
A153 and the andrimid gene clusters of the other producing strains. A, Schematic 
representation of the adm gene cluster in Serratia strains. B-F, Alignments 
representing the percentage of DNA homology between the adm gene cluster of A153 
and those of S. marcescens MSU97 (B), S. marcescens 90-166 (C), Pantoea 
agglomerans Eh335 (D) Vibrio coralliilyticus S2052 (E) and Vibrionales SWAT-3 (F). 
Alignments were performed using wgVISTA (Frazer et al., 2004).  
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Supplementary Fig. S5: Growth of Serratia plymuthica A153 in minimal medium 
with different carbon sources. Growth curves showing the doubling time in sorbitol 
(181.2 ± 1 min), mannitol (153 ± 1 min), fructose (145.8 ± 2 min), galactose (115.2 ± 1 
min), mannose (181.6 ± 2 min), lactose (413.4 ± 6 min), xylose (208.2 ± 2 min), 
succinic acid (142.8 ± 1 min), maltose (145.2 ± 1 min), sucrose (106.2 ± 1 min), 
glucose (115.2 ± 1 min), glycerol (121 ± 1 min), gluconic acid (96.6 ± 1 min), arabinose 
(235.2 ± 2 min) and citrate (158. 7 ± 3 min) as sole carbon source. Data are the mean 
and standard deviation of three biological replicates. The assays were done at 25 ºC 
with shaking at 200 rpm. 
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Supplementary Fig S6: Impact of Hfq (A) and AdmX (B) on the expression of 
admV and admX. Quantitative real-time PCR was used to measure transcript levels of 
admV (grey bars) and admX (white bars) in Serratia plymuthica A153, and derivative 
strains. The values showed the average expression relative to wild type expression. 
The arrow in Fig. 4A indicates the time point when the samples for qPCR were taken. 
The data are the mean and standard deviation of three biological replicates.  
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Supplementary Fig. S7. AdmX transcription correlates with the expression of the 
andrimid gene cluster. Transcription of the admX (PadmX::lacZ; pMAMV244) promoter 
fusion throughout growth in Serratia plymuthica A153 strains. β-Galactosidase activity 
(filled symbols) and growth curves (open symbols) were determined in LacZ (red) and 
∆admX (blue) in LB medium at 25 °C. A153 wt harbouring the empty reporter plasmid 
(black) was used as negative control in the assays. Data are the mean and standard 
deviation of three biological replicates.  
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Supplementary Figure S8. Genetic complementation of Serratia plymuthica A153 
strain A153H. Expression of hfq in trans in A153 ∆hfq restored andrimid production 
and therefore the antibacterial activity against Bacillus subtilis. Induction of Hfq 
expression was done by addition of 0.1 mM of IPTG. The bioassays were repeated at 
least three times, and a representative figure is shown. Pictures were taken after 48 h 
of incubation at 25 °C.  
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Supplementary Figure S9: Sensitivities of different bacterial strains to the 
antibiotic andrimid. Bioactivities of Serratia plymuthica A153 and the non-andrimid 
producing mutant of A153, VN2, against ecologically different bacterial strains. For the 
assays, an indicator top agar lawn was prepared as described in “Experimental 
procedures,” and 5 µl overnight cultures of the A153 strains were spotted on the 
surface of the bacterial indicator agar lawns. The bioassays were repeated three times, 
and representative results are shown. Pictures were taken after 48 h of incubation at 
25 °C. The strains used are described in Table 1 and supplementary Table S2.  
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Supplementary Figure S10: Andrimid shows antibacterial activity against 
Bacillus subtilis, Dickeya solani and Xanthomonas campestris pv. campestris. 
Recovery of viable Bacillus, Dickeya and Xanthomonas cells grown in the presence of 
A153 JH6 (andrimid positive, zeamine negative) and A153 XJH6 (andrimid and 
zeamine negative) supernatants. The values showed the percentage of viable cells in 
the presence of JH6 supernatants relative to the number of viable cells in the presence 
of XJH6 supernatants. For the assays, overnight bacterial cultures of Bacillus, Dickeya 
and Xanthomonas were adjusted to an optical density at 600 nm (OD600) of 0.1 and 
grown at 30 ºC with orbital shaking (225 rpm). At an OD600 of 0.4, 10 mL of the bacterial 
culture was removed and pelleted by centrifugation at 4,000 x g for 10 min at room 
temperature. The pellet was resuspended in 5 ml of 2X LB and 5 ml supernatants of an 
overnight culture of A153 JH6 or A153 XJH6 were added to the bacterial culture. 
Samples were taken after 5 and 10 h of incubation and the number of colony forming 
units (CFU) were determined. Data are the mean and standard deviation of three 
biological replicates.  
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Supplementary Figure S11: Homology model of AdmX. The model was generated 
by the Geno3D modeling algorithm (Combet et al., 2000) and the structure of the BenM 
transcriptional regulator (PDB ID 3K1N) as template. The site for the binding of 
potential effector molecules is indicated.  
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